• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Zogenix, Inc. (ZGNX)

    -NasdaqGM
    1.35 Down 0.02(1.46%) Jan 30, 4:00PM EST
    |After Hours : 1.45 Up 0.10 (7.41%) Jan 30, 7:59PM EST
    Add to Portfolio
    Prev Close:1.37
    Open:1.38
    Bid:1.36 x 100
    Ask:N/A
    1y Target Est:2.75
    Beta:1.12
    Earnings Date:Mar 3 - Mar 9 (Est.)
    Day's Range:1.35 - 1.43
    52wk Range:1.07 - 5.19
    Volume:3,542,525
    Avg Vol (3m):2,325,180
    Market Cap:206.60M
    P/E (ttm):N/A
    EPS (ttm):-0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ZGNX

    Comparison

    Symbol% ChgMkt Cap
    ZGNXDown 1.46%206.60M
    AZNDown 1.18%89.72B
    GSKDown 2.57%105.78B
    PFEDown 1.82%196.90B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5.90
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.66
    Quarterly EPS Est (Dec-14) :-0.11
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):-0.08

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders and pain. The company’s commercial product includes Zohydro, a single-entity extended-release hydrocodone for... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback